Muted bromine business; outlook improving Archean Chemical’s (ACI) Q1FY24 EBITDA dipped ...
Earnings miss; outlook encouraging for bromine demand Archean’s 1QFY24 earnings print wa...
Bromine demand outlook buoyant; maintain BUY Archean’s 4QFY23 EBITDA was 4% below our ex...
Bromine business to face near-term challenges Archean Chemical’s (ACI) Q4FY23 EBITDA gre...
Archean Chemical Industries Building on the Bromine Advantage Capitalising on India’s...
Archean Chemical Industries has debuted at Rs 449.00 on the BSE, up by 42 points or 10.32% from i...
A leading B2B player in the specialty marine chemicals KEY CHANGES: TARGET Archean Chemical In...
Salient features of the IPO: • Archean Chemical Industries Ltd. (ACIL), a specialty marin...